One-year worsening heart failure and myocardial T1 mapping in patients with wild-type transthyretin amyloid cardiomyopathy undergoing tafamidis treatment [0.03%]
接受塔法莫迪斯治疗的野生型甲状腺素转运蛋白心肌病患者一年内心脏衰竭恶化和心肌T1图变化
Toshiro Kitagawa,Kotaro Hamamoto,Daiki Okamoto et al.
Toshiro Kitagawa et al.
Background: There is a paucity of data regarding short-term outcomes and treatment responsiveness of myocardial T1 mapping via cardiac magnetic resonance (CMR) in patients with transthyretin amyloid cardiomyopathy (ATTR-C...
Peak aortic jet velocity as a predictor of short- and long-term outcomes following percutaneous coronary intervention [0.03%]
经皮冠状动脉介入治疗术后主动脉喷射速度峰值对短期和长期预后的预测价值
Takamasa Iwai,Kensuke Takagi,Takeshi Kitai et al.
Takamasa Iwai et al.
Background: Coronary artery disease (CAD) and aortic valve stenosis (AS) often coexist, with AS exacerbating myocardial ischemia and affecting prognosis. ...
Revisiting outcomes after transcatheter aortic valve replacement: The need for a multidimensional approach to patient management [0.03%]
经导管主动脉瓣置换术后结果的再评价:患者管理多维度方法的需求
Carmelita Cieri,Michele Russo,Marco Zimarino
Carmelita Cieri
Cardiac dysfunction after acute ischaemic stroke: Long-term outcomes from the SICFAIL cohort [0.03%]
急性缺血性卒中后的心脏功能障碍:来自SICFAIL队列的长期结果分析
Kathrin Ungethüm,Felipe A Montellano,Viktoria Rücker et al.
Kathrin Ungethüm et al.
Background: Systolic dysfunction, diastolic dysfunction, and clinically overt heart failure are frequently encountered after acute ischaemic stroke. We investigated whether these cardiac phenotypes, considered as distinct...
Risk prediction of atrial fibrillation progression in patients with paroxysmal atrial fibrillation: data from the RACE V study [0.03%]
阵发性房颤患者向持续性房颤进展的风险预测:来自RACE V研究的数据
D K Baron,M Samuel,H J G M Crijns et al.
D K Baron et al.
Background: Atrial Fibrillation (AF) may progress from paroxysmal AF (PAF) to more sustained forms, but predicting which patients progress remains a challenge. The RACE V study is a prospective, observational study aiming...
Persistent left superior vena cava is associated with complex atrial tachyarrhythmias in repaired tetralogy of Fallot: evidence for a right-sided arrhythmogenic substrate [0.03%]
持续存在的左侧上腔静脉与修复后的法洛四联症的复杂房性快速心律失常相关:右侧心律失常发病机制的证据
Tabito Kino,Miyako Igarashi,Yuta Suto et al.
Tabito Kino et al.
Background: Atrial fibrillation (AF) is an important late complication in patients with repaired tetralogy of Fallot (TOF); however, its clinical determinants and arrhythmogenic substrates remain uncertain. Identifying hi...
Phenotype-stratified treatment response in obese atrial fibrillation: Post-hoc cluster analysis of the PRAGUE-25 randomized trial [0.03%]
基于PRAGUE-25随机试验的事后聚类分析:肥胖房颤的表型分层治疗反应
Ivan Ranic,Ladislav Stanke,Otakar Jiravsky et al.
Ivan Ranic et al.
Background: The PRAGUE-25 trial demonstrated catheter ablation (CA) superiority over lifestyle modification plus antiarrhythmic drugs (LFM + AAD) in obese patients with atrial fibrillation (AF). However, obese AF patients...
Efficacy and safety of mavacamten in non-obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis of randomized trials [0.03%]
马卡他品治疗非梗阻性肥厚型心肌病的疗效和安全性:随机试验的系统评价和meta分析
Muhammad Abdullah,Husna Irfan Thalib,Mustafa Bin Tahir et al.
Muhammad Abdullah et al.
Background: Non-obstructive hypertrophic cardiomyopathy (nHCM) remains a therapeutic challenge, with limited pharmacological options beyond symptomatic management. Mavacamten, a selective allosteric cardiac myosin inhibit...
Myval Octacor and Octapro T rans-Catheter Heart Valves in Patients with Severe Pure Non Calcified Native Aortic Regurgitation [0.03%]
Myval八叶皮瓣和Octapro八叶导管主动脉瓣用于重度非钙化性单纯主动脉瓣关闭不全患者的治疗
Alfonso Ielasi,Rodolfo Caminiti,Mariano Pellicano et al.
Alfonso Ielasi et al.
Background: the treatment of high-risk or inoperable patients with severe, pure native non calcified aortic regurgitation (NCAR) poses unique procedural challenges for the trans-catheter technologies. In particular the la...
Premature ventricular complexes increase with heart rate in patients with mitral valve prolapse [0.03%]
二尖瓣脱垂患者室性期前收缩的发生率随心率的增加而增加
Cecilie Bugge,Christian K Five,Tariq Ahmed et al.
Cecilie Bugge et al.
Background: Patients with mitral valve prolapse (MVP) are at risk of ventricular arrhythmias (VAs), ranging from premature ventricular complexes (PVCs) to life-threatening VAs. The association between PVC burden and heart...